These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22552587)

  • 1. Myeloid-derived suppressor cells in sepsis: friend or foe?
    Cuenca AG; Moldawer LL
    Intensive Care Med; 2012 Jun; 38(6):928-30. PubMed ID: 22552587
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloid-derived suppressor cells control microbial sepsis.
    Derive M; Bouazza Y; Alauzet C; Gibot S
    Intensive Care Med; 2012 Jun; 38(6):1040-9. PubMed ID: 22552586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nfia deletion in myeloid cells blocks expansion of myeloid-derived suppressor cells during sepsis.
    Dai J; Kumbhare A; Williams DA; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    Innate Immun; 2018 Jan; 24(1):54-65. PubMed ID: 29172874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of immune tolerance unmasks drug-induced allergic hepatitis.
    Uetrecht J; Kaplowitz N
    Hepatology; 2015 Aug; 62(2):346-8. PubMed ID: 25833746
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained.
    Ko JS; Rayman P; Ireland J; Swaidani S; Li G; Bunting KD; Rini B; Finke JH; Cohen PA
    Cancer Res; 2010 May; 70(9):3526-36. PubMed ID: 20406969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b.
    Alkhateeb T; Kumbhare A; Bah I; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    Mol Immunol; 2019 Aug; 112():72-81. PubMed ID: 31078118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced allergic hepatitis develops in mice when myeloid-derived suppressor cells are depleted prior to halothane treatment.
    Chakraborty M; Fullerton AM; Semple K; Chea LS; Proctor WR; Bourdi M; Kleiner DE; Zeng X; Ryan PM; Dagur PK; Berkson JD; Reilly TP; Pohl LR
    Hepatology; 2015 Aug; 62(2):546-57. PubMed ID: 25712247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody.
    Nigam S; McCarl L; Kumar R; Edinger RS; Kurland BF; Anderson CJ; Panigrahy A; Kohanbash G; Edwards WB
    Mol Imaging Biol; 2020 Jun; 22(3):685-694. PubMed ID: 31529407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
    Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
    Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.
    Serafini P; Mgebroff S; Noonan K; Borrello I
    Cancer Res; 2008 Jul; 68(13):5439-49. PubMed ID: 18593947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
    Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFI-A disrupts myeloid cell differentiation and maturation in septic mice.
    McClure C; Ali E; Youssef D; Yao ZQ; McCall CE; El Gazzar M
    J Leukoc Biol; 2016 Jan; 99(1):201-11. PubMed ID: 26259914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The terminology issue for myeloid-derived suppressor cells.
    Gabrilovich DI; Bronte V; Chen SH; Colombo MP; Ochoa A; Ostrand-Rosenberg S; Schreiber H
    Cancer Res; 2007 Jan; 67(1):425; author reply 426. PubMed ID: 17210725
    [No Abstract]   [Full Text] [Related]  

  • 14. CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer.
    Feng PH; Lee KY; Chang YL; Chan YF; Kuo LW; Lin TY; Chung FT; Kuo CS; Yu CT; Lin SM; Wang CH; Chou CL; Huang CD; Kuo HP
    Am J Respir Crit Care Med; 2012 Nov; 186(10):1025-36. PubMed ID: 22955317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor.
    Connolly MK; Mallen-St Clair J; Bedrosian AS; Malhotra A; Vera V; Ibrahim J; Henning J; Pachter HL; Bar-Sagi D; Frey AB; Miller G
    J Leukoc Biol; 2010 Apr; 87(4):713-25. PubMed ID: 20042467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.
    Görgün GT; Whitehill G; Anderson JL; Hideshima T; Maguire C; Laubach J; Raje N; Munshi NC; Richardson PG; Anderson KC
    Blood; 2013 Apr; 121(15):2975-87. PubMed ID: 23321256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion.
    Dugast AS; Haudebourg T; Coulon F; Heslan M; Haspot F; Poirier N; Vuillefroy de Silly R; Usal C; Smit H; Martinet B; Thebault P; Renaudin K; Vanhove B
    J Immunol; 2008 Jun; 180(12):7898-906. PubMed ID: 18523253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.
    Poh TW; Bradley JM; Mukherjee P; Gendler SJ
    Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines.
    Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL
    J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antigen-specific suppressor factors--serology, structure and function].
    Skibiński G
    Postepy Hig Med Dosw; 1985; 39(3):229-44. PubMed ID: 2421279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.